Current Report Filing (8-k)
May 15 2018 - 6:11AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
May 14, 2018
Mustang Bio, Inc.
(Exact Name of Registrant as Specified in
Charter)
Delaware
(State or Other Jurisdiction
of Incorporation)
|
|
001-38191
(Commission File Number)
|
|
47-3828760
(IRS Employer Identification No.)
|
2 Gansevoort Street, 9th Floor
New York, New York 10014
(Address of Principal Executive Offices)
(781) 652-4500
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the
Securities Act.
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act.
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2b
under the Exchange Act.
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act.
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company
x
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.
x
|
Item 2.02.
|
Results of Operations and Financial Condition.
|
On May 14, 2018, Mustang Bio, Inc. (the “Company”)
issued a press release to announce its financial results and recent corporate highlights for the first quarter ended March 31,
2018. A copy of such press release is being furnished as Exhibit 99.1 to this report.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits.
The following exhibit is furnished herewith:
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 15, 2018
|
Mustang Bio, Inc.
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Manuel Litchman, M.D.
|
|
|
|
Manuel Litchman, M.D.
|
|
|
|
President and Chief Executive Officer
|
|
Mustang Bio (NASDAQ:MBIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Mustang Bio (NASDAQ:MBIO)
Historical Stock Chart
From Apr 2023 to Apr 2024